SUPN · NASDAQ · Drug Manufacturers - Specialty & Generic

Supernus Pharmaceuticals (SUPN)

Develops CNS medicines spanning ADHD, Parkinson’s disease, postpartum depression, and epilepsy.

$43.75
After hours−0.04 (−0.09%)
At close$43.79(+2.36%)